Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rivaroxaban in Pediatric Deep Venous Thrombosis
NCT07618988Phase 4Completed
- Sponsor
- Ain Shams University
- Start
- Aug 2024
- Primary completion
- Dec 2025
- Countries
- 1
01
Overview
Phase 4, randomised trial of rivaroxaban in deep vein thrombosis (DVT) (2 arms), sponsored by Ain Shams University. Primary endpoint: Degree of vein recanalization at 3 months. Started Aug 2024; status: completed.
02
Drugs
rivaroxaban
03
Conditions
deep vein thrombosis (DVT)
Beyond the preview
Go deeper on NCT07618988.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07618988.